Our study additionally proposes a possible role for tumors to attract FoxP3+, as well as CD163+ cells, that may afterwards participate in suppression pathways, resulting in the impairment of endogenous antitumor immune responses within the tumor microenvironment. This evidence concerns the gene CD163 and neoplasm.